Header Logo

Connection

Raymond Siatkowski to Angiogenesis Inhibitors

Back to Details
This is a "connection" page, showing publications Raymond Siatkowski has written about Angiogenesis Inhibitors.
Raymond Siatkowski
Connection Strength
0.075
Angiogenesis Inhibitors
  1. Short-term Outcomes After Very Low-Dose Intravitreous Bevacizumab for Retinopathy of Prematurity. JAMA Ophthalmol. 2020 06 01; 138(6):698-701.
    View in: PubMed
    Score: 0.041
  2. Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity: A Phase 1 Dosing Study. JAMA Ophthalmol. 2017 06 01; 135(6):654-656.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.